Tineke E. Buffart
Papers
1
Total Citations
47
H-Index
1
About
Dr. Tineke E. Buffart is a leading clinical researcher in surgical oncology and interventional radiology, with a primary focus on optimizing local treatments for colorectal liver metastases (CRLM). Her major contributions center on high-impact, practice-changing randomized controlled trials that compare surgical resection with thermal ablation. Notably, she is a key investigator in the landmark COLLISION trial—an international, multicenter, phase III study that challenges the standard of care by demonstrating that thermal ablation offers a superior safety profile, lower costs, and shorter hospital stays while achieving comparable oncologic outcomes for small-size CRLM. This work, already cited 47 times since its 2024 publication, has reshaped clinical decision-making for patients with limited liver disease. Dr. Buffart’s research bridges the gap between surgery and minimally invasive techniques, providing robust evidence that expands treatment options and reduces morbidity. Her achievements underscore a commitment to rigorous, patient-centered trial design, making her a pivotal figure in advancing evidence-based, less invasive cancer care.
Research Focus
Key Achievements
Top Papers
- 1